Chesney Castleberry, M.D.

Profile picture
Assistant Professor of Pediatrics, Cardiology

phone: (314) 454-6095

Clinical Interests

Primary clinical interest is in the field of heart failure, cardiomyopathy, mechanical circulatory support, and heart transplantation. Also have clinical interest in aquired immune deficiencies especially as they relate to sequale of cardiac operations and transplantation.


  • BA, Texas A&M University2001
  • MD, University of Texas Medical School2005


  • Resident, Children’s Memorial Hospital2005 - 2008
  • Fellow, Children’s Hospital of Wisconsin2008 - 2011
  • Advanced Fellow, Lucile Packard Children’s Hospital2011 - 2012
  • Masters of Science in Clinical Investigation, Washington University in St. Louis School of Medicine2017

Licensure and Board Certification

  • 2008 - 2011WI, Wisconsin License
  • 2009 - 2017American Board of Pediatrics
  • 2012 - 2013CA, California License
  • 2012Advanced Cardiovascular Life Support
  • 2013 - 2023American Board of Pediatric Cardiology
  • 2013Heartware
  • 2013 - 2015OH, Ohio License
  • 2013Thoratec Centrimag/Pedimag
  • 2013 - 2015KY, Kentucky License
  • 2014Syncardia C2
  • 2014Syncardia Freedom Driver
  • 2014Thoratec Heartmate II
  • 2015Pediatric Advanced Life Support
  • 2015 - 2018MO, Missouri License


  • Medical College of Wisconsin Fellow Research Award2010
  • International Society of Heart and Lung Transplant Registry, Early Career Award2014
  • Mentor- Summer Undergraduate Research Fellowship, Capstone Poster Presentation- 1st Place Award2015
  • Washington University Academic Medical Leadership Program for Physicians and Scientists2018
  • American Academy of Medical Colleges Early Career Women Faculty Leadership Seminar2019

Recent Publications view all (23)

Publication Co-Authors

  1. Moderate-severe primary graft dysfunction after pediatric heart transplantation. Pediatr Transplant. 2019;e13340. PMID:30609166 
  2. Fontan-associated protein-losing enteropathy and post‒heart transplant outcomes: A multicenter study. J Heart Lung Transplant. 2019;38(1):17-25. PMID:30391195 
  3. Early stroke post-heart transplant is associated with decreased survival in children. J Heart Lung Transplant. 2018;37(6):733-739. PMID:29395751 
  4. No Obesity Paradox in Pediatric Patients With Dilated Cardiomyopathy. JACC Heart Fail. 2018;6(3):222-230. PMCID:PMC5834393  PMID:29428438 
  5. End-stage renal disease after pediatric heart transplantation: A 25-year national cohort study. J Heart Lung Transplant. 2017. PMCID:PMC5880747  PMID:29055603 
  6. Pediatric Cardiomyopathies. Circ Res. 2017;121(7):855-873. PMID:28912187 
  7. Clinical practice patterns are relatively uniform between pediatric heart transplant centers: A survey-based assessment. Pediatr Transplant. 2017;21(5). PMID:28670871 
  8. A Novel Surgical Approach to Mechanical Circulatory Support in Univentricular Infants. Ann Thorac Surg. 2017. PMID:28720202 
  9. Risk stratification to determine the impact of induction therapy on survival, rejection and adverse events after pediatric heart transplant: A multi-institutional study. J Heart Lung Transplant. 2017. PMID:28619384 
  10. Pediatric Heart Transplantation Long-Term Survival in Different Age and Diagnostic Groups: Analysis of a National Database. World J Pediatr Congenit Heart Surg. 2017;8(3):337-345. PMID:29957123 
  11. Interaction of older donor age and survival after weight-matched pediatric heart transplantation. J Heart Lung Transplant. 2017;36(5):554-558. PMID:28073609 
  12. Development and validation of a major adverse transplant event (MATE) score to predict late graft loss in pediatric heart transplantation. J Heart Lung Transplant. 2017. PMID:28465118 
  13. Breaking the rules-Higher urgency listings by exception: Challenges when a child's life is at stake. J Heart Lung Transplant. 2017;36(3):256-257. PMID:28065653 
  14. Outcomes and Trends of Ventricular Assist Device Selection in Children with End-Stage Heart Failure. ASAIO J. 2017;63(4):464-469. PMID:28009713 
  15. Transplant Survival After Berlin Heart EXCOR Support. ASAIO J. 2017;63(1):80-85. PMID:27660899 
  16. Allosensitization does not alter post-transplant outcomes in pediatric patients bridged to transplant with a ventricular assist device. Pediatr Transplant. 2016;20(4):559-64. PMID:27102953 
  17. Early initiation of mTOR inhibitors in children with heart transplantation: A propensity-based registry analysis. J Heart Lung Transplant. 2016;35(2):253-5. PMID:26612055 
  18. Basiliximab treatment for autoimmune bowel disease in a pediatric heart transplant patient. Pediatr Transplant. 2015;19(7):E165-9. doi:10.1111/petr.12584  PMID:26374667 
  19. Pediatric heart transplant waiting list mortality in the era of ventricular assist devices. J Heart Lung Transplant. 2015;34(1):82-8. doi:10.1016/j.healun.2014.09.018  PMID:25447574 
  20. Transplantation in the highly sensitized pediatric patient. Circulation. 2014;129(22):2313-9. PMID:24891624 
  21. Hypoalbuminemia and poor growth predict worse outcomes in pediatric heart transplant recipients. Pediatr Transplant. 2014;18(3):280-7. doi:10.1111/petr.12239  PMID:24646199 
  22. Highly sensitive noninvasive cardiac transplant rejection monitoring using targeted quantification of donor-specific cell-free deoxyribonucleic acid. J Am Coll Cardiol. 2014;63(12):1224-6. doi:10.1016/j.jacc.2013.09.029  PMID:24140666 
  23. Stenting of the right ventricular outflow tract in the high-risk infant with cyanotic teratology of Fallot. Pediatr Cardiol. 2014;35(3):423-30. doi:10.1007/s00246-013-0796-z  PMID:24096718 
Last updated: 02/21/2019
© 2019 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130